Spruce Biosciences annual total assets
2019
2020
2021
2022
2023
2024
2025
Spruce Biosciences Total Assets Growth & History (SPRB)
Spruce Biosciences's total assets was $53.0M for fiscal 2025.
View full Spruce Biosciences company overviewSpruce Biosciences annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $53.0M | $7.8M | +17.28% |
| 2024 | 2024-12-31 | $45.2M | −$58.7M | −56.51% |
| 2023 | 2023-12-31 | $103.9M | $18.3M | +21.36% |
| 2022 | 2022-12-31 | $85.6M | −$40.8M | −32.29% |
| 2021 | 2021-12-31 | $126.5M | −$36.4M | −22.35% |
| 2020 | 2020-12-31 | $162.9M | $158.2M | +3371.50% |
| 2019 | 2019-12-31 | $4.7M | — | — |
Spruce Biosciences quarterly total assets
Q4.19
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $102.9M | $81.0M | +371.37% |
| Q1 2026 | 2026-03-31 | $56.2M | $24.5M | +77.47% |
| Q4 2025 | 2025-12-31 | $53.0M | $7.8M | +17.28% |
| Q3 2025 | 2025-09-30 | $15.3M | −$49.8M | −76.48% |
| Q2 2025 | 2025-06-30 | $21.8M | −$53.7M | −71.11% |
| Q1 2025 | 2025-03-31 | $31.6M | −$55.9M | −63.85% |
| Q4 2024 | 2024-12-31 | $45.2M | −$58.7M | −56.51% |
| Q3 2024 | 2024-09-30 | $65.1M | −$47.9M | −42.38% |
| Q2 2024 | 2024-06-30 | $75.5M | −$50.4M | −40.05% |
| Q1 2024 | 2024-03-31 | $87.5M | −$51.6M | −37.07% |
| Q4 2023 | 2023-12-31 | $103.9M | $18.3M | +21.36% |
| Q3 2023 | 2023-09-30 | $113.0M | $17.7M | +18.56% |
| Q2 2023 | 2023-06-30 | $126.0M | $21.4M | +20.52% |
| Q1 2023 | 2023-03-31 | $139.1M | $24.1M | +20.98% |
| Q4 2022 | 2022-12-31 | $85.6M | −$40.8M | −32.29% |
| Q3 2022 | 2022-09-30 | $95.3M | −$39.8M | −29.45% |
| Q2 2022 | 2022-06-30 | $104.5M | −$38.9M | −27.14% |
| Q1 2022 | 2022-03-31 | $115.0M | −$39.0M | −25.33% |
| Q4 2021 | 2021-12-31 | $126.5M | −$36.4M | −22.35% |
| Q3 2021 | 2021-09-30 | $135.1M | $56.6M | +72.12% |
| Q2 2021 | 2021-06-30 | $143.4M | — | — |
| Q1 2021 | 2021-03-31 | $154.0M | — | — |
| Q4 2020 | 2020-12-31 | $162.9M | $158.2M | +3371.50% |
| Q3 2020 | 2020-09-30 | $78.5M | — | — |
| Q4 2019 | 2019-12-31 | $4.7M | — | — |
Spruce Biosciences total assets trends
Over the last five fiscal years, Spruce Biosciences's total assets decreased from $162.9M to $53.0M, a change of −$109.9M. The latest reported quarter, Q2 2026, shows $102.9M.
About the metric
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
Calculation and source
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Spruce Biosciences source filings ↗